These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6505601)

  • 1. [Long-term treatment of systemic scleroderma with coagulation factor XIII. Developmental monitoring, especially of respiratory function].
    Euller-Ziegler L; Corolleur YR; Marcou J; Commandre F; Grisot C; Ziegler G
    Rev Rhum Mal Osteoartic; 1984 Oct; 51(9):503-5. PubMed ID: 6505601
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic action of coagulation factor XIII in scleroderma. 20 cases].
    Thivolet J; Perrot H; Meunier F; Bouchet B
    Nouv Presse Med; 1975 Nov; 4(39):2779-82. PubMed ID: 1105424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of systemic scleroderma with factor XIII in 86 patients, with long-term follow-up].
    Guillevin L; Euller-Ziegler L; Chouvet B; De Gery A; Chassoux G; Lafay P; Ziegler G; Godeau P; Amor B; Thivolet J
    Presse Med; 1985 Dec; 14(46):2327-9. PubMed ID: 2935830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation factor XIII, endothelial damage and systemic sclerosis.
    Marzano AV; Federici AB; Gasparini G; Mannucci PM; Caputo R; Berti E
    Eur J Dermatol; 2000; 10(1):14-7. PubMed ID: 10694291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Favorable effects of plasma factor XIII on lower esophageal sphincter pressure of progressive systemic sclerosis.
    Maekawa Y; Nogita T; Yamada M
    Arch Dermatol; 1987 Nov; 123(11):1440-1. PubMed ID: 3674907
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bronchiolo-alveolar carcinoma complicating systemic scleroderma under long-term treatment with factor XIII].
    Grivaux M; Pieron R
    Rev Pneumol Clin; 1987; 43(2):102-3. PubMed ID: 3039643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation factor XIII in scleroderma.
    Jullien D; Souillet AL; Faure M; Claudy A
    Eur J Dermatol; 1998 Jun; 8(4):231-4. PubMed ID: 9649677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of progressive systemic sclerosis using factor XIII.
    Guillevin L; Chouvet B; Mery C; De Gery A; Thivolet J; Godeau P; Delbarre F
    Pharmatherapeutica; 1985; 4(2):76-80. PubMed ID: 3903781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [External respiratory functions in systemic scleroderma].
    Drampian FS; Manukian DzhA ; Topchian AS; Danilova LL; Azizian AL
    Zh Eksp Klin Med; 1975; 15(2):87-90. PubMed ID: 1136647
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of systemic scleroderma].
    Priollet P; Baudot N; Fiessinger JN; Vayssairat M; Housset E
    Ann Dermatol Venereol; 1984; 111(6-7):595-607. PubMed ID: 6388467
    [No Abstract]   [Full Text] [Related]  

  • 11. Factor XIII treatment for scleroderma.
    Delbarre F; Godeau P; Thivolet J
    Lancet; 1981 Jul; 2(8239):204. PubMed ID: 6114269
    [No Abstract]   [Full Text] [Related]  

  • 12. [Total pulmonary volume and residual air in scleroderma and systemic lupus erythematosus patients].
    Balabaeva PN
    Ter Arkh; 1968 Nov; 40(11):79-81. PubMed ID: 5746749
    [No Abstract]   [Full Text] [Related]  

  • 13. [Examination of lung disorders in generalized scleroderma observed over a long period].
    Morinari G; Koike S; Shiraishi T; Mori M; Mori S
    Naika; 1972 Mar; 29(3):535-42. PubMed ID: 5035842
    [No Abstract]   [Full Text] [Related]  

  • 14. [Respiratory function profile in scleroderma. 20 cases (author's transl)].
    Kleisbauer JP; Feliciano JM; Colonna J; Velardocchio JM; Laval P
    Poumon Coeur; 1980; 36(6):371-6. PubMed ID: 7220421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Longitudinal study of parameters of respiratory function tests and blood gas analysis in patients with progressive systemic scleroderma].
    Georgiev O; Shoshkov P; Rashkov R
    Vutr Boles; 2001; 33(2-3):37-40. PubMed ID: 12001574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic sclerosis after a long-term follow-up].
    Danese C; Zavattaro E; Marcianò F; Sebastiani ML; Perego MA
    Minerva Med; 1994; 85(7-8):359-64. PubMed ID: 7936353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of reflected and direct heat on the peripheral blood vessels in scleroderma].
    Koźmińska A
    Arch Klin Exp Dermatol; 1968; 233(2):146-55. PubMed ID: 5721212
    [No Abstract]   [Full Text] [Related]  

  • 18. A growing need for capillaroscopy in rheumatology.
    De Angelis R; Grassi W; Cutolo M
    Arthritis Rheum; 2009 Mar; 61(3):405-10. PubMed ID: 19248132
    [No Abstract]   [Full Text] [Related]  

  • 19. [Importance of the changes in pulmonary diffusion capacity in the evaluation of the functional respiratory damage in scleroderma].
    Catenacci G; Carosi L
    Folia Med (Napoli); 1967 Dec; 50(12):890-8. PubMed ID: 5617897
    [No Abstract]   [Full Text] [Related]  

  • 20. Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease.
    Mittoo S; Wigley FM; Wise R; Xiao H; Hummers L
    Arthritis Rheum; 2007 Dec; 56(12):4195-202. PubMed ID: 18050251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.